Pentoxifylline and Tocopherol (PENTO) in the Treatment of Medication-related Osteonecrosis of the Jaw (MRONJ): A Prospective, Randomized Controlled Trial to Evaluate a Novel Non-operative Treatment
Phase of Trial: Phase III
Latest Information Update: 22 Apr 2019
Price : $35 *
At a glance
- Drugs Pentoxifylline (Primary) ; Tocopherol (Primary)
- Indications Osteonecrosis
- Focus Therapeutic Use
- 24 Apr 2018 Planned End Date changed from 1 Jan 2019 to 1 Jan 2020.
- 24 Apr 2018 Planned primary completion date changed from 1 Jan 2019 to 1 Jan 2020.
- 24 Apr 2018 Status changed from not yet recruiting to recruiting.